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By cloning into Escherichia coli and construction of isogenic mutants of Haemophilus ducreyi, we showed that
the hemoglobin receptor (HgbA) is TonB dependent. An E. coli hemA tonB mutant expressing H. ducreyi hgbA
grew on low levels of hemoglobin as a source of heme only when an intact H. ducreyi Ton system plasmid was
present. In contrast, growth on heme by the E. coli hemA tonB mutant expressing hgbA was observed only at
high concentrations of heme, was TonB independent, and demonstrated that H. ducreyi HgbA was not sufficient
to function as a typical TonB-dependent heme receptor in E. coli. Allelic replacement of the wild-type H. ducreyi
exbB, exbD, and tonB loci with the exbB, exbD, and tonB deletion resulted in an H. ducreyi isogenic mutant
unable to utilize hemoglobin but able to utilize hemin at the same levels as the parent strain to fulfill its heme
requirement. This finding confirms the TonB dependence of HgbA-mediated hemoglobin utilization and
suggests that uptake of hemin in H. ducreyi is TonB independent. Additionally, the H. ducreyi Ton system
mutant synthesized increased amounts of HgbA and other heme-regulated outer membrane proteins, consis-
tent with derepression of these proteins due to lower intracellular heme and/or iron concentrations in the
mutant. Sequencing of the Ton system genes revealed that the arrangement of the genes was exbB exbD tonB.
The proximity and structure of these genes suggested that they are transcribed as an operon. This arrange-
ment, as well as the DNA and deduced amino acid sequences of these H. ducreyi genes, was most similar to
those from other pasteurellae.
Haemophilus ducreyi is the etiologic agent of chancroid, a
genital ulcer disease transmitted by sexual contact (reviewed in
references 2 and 66). Prevalent in Africa, Asia, and certain
developing nations, chancroid has recently gained importance
as an independent risk factor for the heterosexual transmission
of human immunodeficiency (67). There is accumulating evi-
dence suggesting that the rapid spread of human immunode-
ficiency virus type 1 in eastern and southern Africa has been
due, at least in part, to the presence of chancroid and other
genital ulcer diseases (13, 51). At present no vaccine or prac-
tical field diagnostic test exists for H. ducreyi.
H. ducreyi is a fastidious slow-growing, gram-negative rod
with an optimum growth temperature of 33°C. An important
feature of H. ducreyi is its requirement for heme, which it is
unable to synthesize. This obligate requirement for heme by H.
ducreyi is in contrast with H. influenzae, which is able to use its
enzyme ferrochelatase to ferrate protoporphyrin IX, bypassing
the need for heme (24, 53). In H. ducreyi, heme is acquired
from its only known host, humans, in several possible forms,
including hemoglobin, hemoglobin complexed to haptoglobin,
catalase, free hemin, or heme bound to carrier proteins such as
albumin (3, 39, 64). Some or all of these heme sources could be
released from host cells by the action of the H. ducreyi hemo-
lysin (45, 46, 63) or cytotoxin (16, 37, 49).
Host heme compounds represent important sources of iron
(44). Host iron is sequestered by several mechanisms, and
invading bacteria must gain access to these iron sources to
survive and initiate disease. Some bacteria utilize iron-scaveng-
ing siderophore systems; others directly bind host iron or
heme/iron-containing compounds such as transferrin, lactofer-
rin, heme, or hemoglobin (19, 44). No siderophores have been
found in H. ducreyi (39). Since H. ducreyi requires both heme
and iron, differentiation between the requirement for both of
these can be problematic.
Siderophore receptors and most receptors for host iron-
binding compounds belong to a family of outer membrane
receptors designated TonB dependent because they require
the cytoplasmic membrane protein TonB for activity (7, 11,
57). TonB-dependent receptors are related structurally and
functionally; where studied, they have been shown to form
specific pores for the entry of low-molecular-weight molecules
(12, 40). TonB-dependent receptors for host-iron complexes
such as transferrin or lactoferrin have been shown to internal-
ize the iron only (41), whereas receptors for siderophores in-
ternalize the iron-siderophore complex (43). TonB-dependent
receptors are also related at the amino acid level by virtue of
several regions of distinct homology, including an N-terminal
sequence termed the TonB Box (18, 28, 35, 54). In Escherichia
coli, the TonB protein has been shown to directly interact with
TonB-dependent receptors FepA (5, 55). TonB and its acces-
sory proteins ExbB and ExbD comprise a system for the trans-
fer of energy from the cytoplasmic membrane to outer mem-
brane receptors (10). Null mutations in either tonB, exbB, or
exbD can variably affect the ability of TonB-dependent recep-
tors to internalize or utilize their cognate ligand (48). The
effect of these null mutations can vary from partial to total
inhibition of uptake of ligands.
Previously, we identified and purified an outer membrane
hemoglobin receptor from H. ducreyi termed HgbA (22) and
showed that the HgbA protein is functionally and immunolog-
ically conserved between geographically diverse isolates. Fur-
ther analysis was performed by using molecular techniques (23,
56). The hgbA gene was cloned and sequenced; its deduced
amino acid sequence is similar to the TonB-dependent family
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of outer membrane receptors (23, 56). An hgbA isogenic mu-
tant of H. ducreyi cannot bind or utilize hemoglobin as a source
of heme but can utilize free hemin, implying that the utilization
of hemin does not require HgbA. It has been shown by Stevens
et al. (56) that an isogenic mutant of hgbA (hup) expressed
reduced virulence in an animal model of H. ducreyi infection.
In the course of these functional studies, we found that an E.
coli hemA mutant expressing hgbA binds hemoglobin yet does
not grow on hemoglobin as a porphyrin source (23). This result
suggested that additional components are necessary for utili-
zation of hemoglobin after the binding step. The objective of
the present study was to identify the additional components
necessary for removal of heme from hemoglobin and for the
transport of heme across the outer membrane.
MATERIALS AND METHODS
Strains and media. Bacterial strains used in this study are described in Table
1. For routine growth, H. ducreyi was maintained on chocolate agar plates
prepared by following gonococcal medium base (GCB) instructions (Difco). No
fetal bovine serum was utilized in chocolate agar plates used for routine passage.
Plates containing the various heme sources were prepared by using GCB and
IsoVitaeleX supplements (Difco) (termed GCB-I). Human hemoglobin (H7379;
Sigma Chemical, St. Louis, Mo.) was dissolved in phosphate-buffered saline at a
concentration of 10 mg/ml and rocked at room temperature for 2 h or overnight
at 4°C prior to filter sterilization. Heme (Sigma) was made 10 mg/ml in 0.1 N
NaOH and was used without sterilization. To bind heme to either serum or
serum proteins, various amounts of heme were added to the protein source and
allowed to bind for at least 10 min at room temperature prior to incorporation
into GCB-I plates. Human serum albumin (HSA; Sigma) was saturated to 50%
by the addition of 1/2 mol of hemin per mol of albumin. We assumed that the
albumin contained no hemin to start with and that it contained a single hemin
binding site. Catalase was obtained from Sigma (C-100, lot no. 106H7055; C-
6655, lot no. 23H70355). Five micrograms of hemin per milliliter corresponds to
7.6 mM hemin.
E. coli hemA mutants EB53 and IR754 were maintained on LB agar plates
containing 25 mM d-aminolevulonic (dALA) acid with antibiotic selection where
appropriate. Antibiotics were used at the following concentrations for E. coli:
ampicillin, 100 mg/ml; chloramphenicol, 30 mg/ml; kanamycin, 30 mg/ml; and
tetracycline, 12 mg/ml. Antibiotic concentrations for H. ducreyi were 1 mg/ml
(chloramphenicol) and 20 mg/ml (kanamycin).
Growth conditions for testing phenotypes. For inoculation of plates for testing
phenotypes, H. ducreyi strains were heme starved by growth anaerobically on
GCB-I plates without a heme source (56). This method of inoculation reduced
the possibility of heme carryover or differences in intracellular heme stores
among the various strains. After H. ducreyi was grown anaerobically on GCB-I
plates, inocula were standardized spectrophotometrically and 10-fold dilutions
were made for each strain in a microtiter tray. A Steers replicator was used to
inoculate agar medium containing dilutions of each heme source. Thus, the
inoculum and heme sources were present in a checkerboard titration. Plates were
incubated at 35°C in 5% CO2.
Outer membrane isolation and analysis. Large-scale cultures of H. ducreyi
were performed in Fernbach flasks with 1 liter of GCB-I broth containing 5%
fetal calf serum (FCS) and heme at 2 mg/ml (heme limiting) or 50 mg/ml (heme
replete) (22). It has been shown by several investigators that H. ducreyi and H.
influenzae strains require less hemin when grown in liquid media compared to
solid medium (3, 22, 60, 64). Therefore, these concentrations should not be
compared with those used in solid medium used for testing phenotypes. Flasks
were inoculated to a starting density of 2.4 3 106 CFU/ml with growth harvested
from chocolate agar plates and were incubated 24 h with shaking in a 5% CO2
atmosphere at 35°C. The purity of each culture was routinely verified by streak-
ing onto agar plates which did (chocolate agar) and did not support the growth
of H. ducreyi but which supported the growth of most other bacteria (GCB-I,
without hemin). This ensured that minor contamination could be detected and
that the novel (previously undescribed) proteins detected (see Fig. 5A) were not
the result of contamination. Outer membranes were harvested as previously
described (22) except that lysozyme was added to the harvested cells prior to the
French press step (200 mg/ml, 10 min, 4°C) and two solubilizations were per-
formed with Sarkosyl rather than one. Protein concentrations were determined
by using a bicinchoninic acid kit from Pierce (Rockford, Ill.). Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting
were performed as previously described (22) except for the antiserum to HgbA.
Anti-HgbA was produced by immunizing mice with 25 mg of purified HgbA (22)
three times at 2-week intervals. Complete Freund’s adjuvant was used for the
first immunization, and incomplete Freund’s adjuvant was used for the last two
immunizations.
Chemicals and reagents. All chemicals and reagents, unless otherwise noted,
were from Sigma.
DNA manipulations. Standard recombinant DNA methods were used as de-
scribed in reference 52 or following manufacturers’ instructions.
The 8.5-kb EcoRI fragment of pUNCH 579 containing the entire hgbA gene
and promoter was ligated into the EcoRI site of pACYC184 (15) to construct
pUNCH 556. Expression of hgbA in E. coli IR754(pUNCH 556) was confirmed
by Western blotting as previously described (22).
For construction of a library from strain 35000, chromosomal DNA was par-
tially restricted with Sau3A1 under limiting enzyme conditions, and 5- to 12-kb
fragments were isolated from a preparative gel. These fragments were ligated
into the BamHI site of purified pBluescript SK(2) vector. To avoid restriction in
subsequent hosts, E. coli DH5aMCR was transformed with the ligation mixture,
the resulting ampicillin-resistant transformants were pooled, and plasmid DNA
was isolated by using the Magic Miniprep procedure (Promega). To clone the
Ton system, this plasmid pool was electroporated into E. coli IR754(pUNCH
556), and selection was performed on LB agar containing hemoglobin (100
mg/ml), ampicillin (100 mg/ml), and tetracycline (10 mg/ml).
DNA sequencing and analysis. DNA sequence analysis was performed at the
University of North Carolina at Chapel Hill Automated Sequencing Facility,
using Taq terminator chemistry. Both strands were completely sequenced and
assembled by using AssemblyLIGN software (IBI). Amino acid alignments were
done with the programs PILEUP and PRETTYBOX (25, 50). The default
threshold parameters for PRETTYBOX were used: 1.5, identical (black boxes);
1.0, similar (dark grey boxes); 0.5, somewhat similar (light grey); 0.0, dissimilar
(white boxes) (see Fig. 2). Table 2 was constructed by using data generated from
the program OLDDISTANCES (25, 50).
Subcloning and construction of an H. ducreyi mutant. pUNCH 562 was sub-
cloned by removal of two small HincII fragments by restriction and religation of
the gel-purified 6.5-kb fragment to form pUNCH 563 (Fig. 1). pUNCH 563 was
mutagenized by restriction with BbsI and MluI followed by Klenow enzyme
treatment to create blunt ends (Fig. 1). A chloramphenicol-resistant (Cmr)
cassette was isolated from plasmid pNC40 (61) by digestion with BglII and end
repair using Klenow enzyme. This cassette was ligated to digested pUNCH 563
to form pUNCH 568 (Fig. 1). The deleted DNA between the BbsI and MluI sites
of pUNCH 563 contains sequences encoding the C terminus of ExbB, all of
ExbD, and the N terminus of TonB. E. coli IR754(pUNCH 556) was electropo-









EB53 hemA aroB rpoB 58
IR754 EB53, but tonB::Kanr 59
DH5aMCR recA gyrB Bethesda Research
Laboratories
H. ducreyi
35000 Wild type Stanley Spinola,
Indiana University
FX504 hgbA 23
FX514 DexbB exbD tonB This work
FX514 repair Wild type This work
FX514(pUNCH
1210)
Wild type This work
Plasmids
pUNCH 579 ColE1 replicon, hgbA Apr 23
pUNCH 556 p15 replicon, hgbA Ter This work
pUNCH 562 ColE1 replicon, exbB exbD
tonB Apr
This work
pUNCH 563 ColE1 replicon, exbB1 exbD1
tonB1 Apr, subclone of
pUNCH 562
This work
pUNCH 568 ColE1 replicon, DexbB exbD
tonB Apr Cmr, deletion
mutant of pUNCH 563
This work
pBluescript ColE1 replicon, Apr Stratagene
pACYC184 p15 replicon, Cmr Ter 1
pGJ300 pLS88 replicon, exbB exbD
tonB Kanr Sulfr Strr
33, 34
pLS88 H. ducreyi shuttle plasmid,
Kanr Sulfr Strr
21
pUNCH 1210 pLS88 containing pUNCH 563
insert in EcoRI site, Kanr
This work
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rated with pUNCH 568, and transformants were selected on LB agar containing
chloramphenicol (30 mg/ml), tetracycline (10 mg/ml), and dALA (25 mg/ml). To
compare the phenotypes of E. coli IR754(pUNCH 556) containing pUNCH 563
and its mutagenized counterpart pUNCH 568, single colonies of each were
streaked onto LB medium containing ampicillin, tetracycline, and either hemo-
globin or dALA and on free hemin or 50% heme-saturated human albumin (Fig.
1 and 3).
An isogenic mutant (FX514 [Table 1]) was constructed by allelic replacement
of the wild-type locus of strain 35000 with the mutation in pUNCH 568 (Fig. 1).
Electroporation of strain 35000 was performed by using 1 mg of XbaI- and
XhoI-restricted pUNCH 568 and selection on 1 mg of chloramphenicol per ml in
chocolate agar plates as previously described (23, 27). Cmr isolates were tested
for inability to grow on hemoglobin agar plates. Strain 35000 and FX504 hgbA
were used as growth controls for the hemoglobin plates.
Southern blot analysis was used to confirm that the genetic event that occurred
in construction of H. ducreyi mutant FX514 was the result of a double crossover.
Chromosomal DNA was isolated, restricted with KpnI and HincII, and subjected
to electrophoresis and bidirectional transfer. One blot was probed with the insert
from pUNCH 563 (Ton system probe), and the other was probed with pNC40
(chloramphenicol acetyltransferase [CAT] probe). Probes were labeled with
digoxigenin by using a Genius random primed kit (Boehringer Mannheim).
Bound probe was detected with alkaline phosphatase-labeled antidigoxigenin
antibody (Boehringer Mannheim) followed by detection with nitroblue tetrazo-
lium and 5-bromo-4-chloro-3-indolylphosphate.
Repair of the chromosomal defect in Ton mutant FX514 was accomplished by
electroporation of XhoI-XbaI-restricted pUNCH 563 into FX514 and plating on
hemoglobin agar without an expression period. H. ducreyi isolates that survived
multiple passages on hemoglobin agar and that were sensitive to chloramphen-
icol were subjected to Southern analysis. All 12 isolates regained the wild-type
Southern blotting pattern of parent 35000, using pUNCH 563 and CAT probes
as shown in Fig. 1 (Southern data for repaired FX514 not shown).
To complement FX514 in trans, the XhoI-XbaI insert from pUNCH 563 was
Klenow enzyme treated and ligated into EcoRI-restricted, Klenow enzyme-
treated vector pLS88 (21, 68). E. coli IR754(pUNCH 579) was electroporated
and plated onto LB hemoglobin agar containing appropriate antimicrobials.
Several complementing plasmids were then moved to E. coli DH5aMCR and
confirmed by restriction. One plasmid, designated pUNCH 1210, was electropo-
rated into FX514, and selection was done on GCB-I hemoglobin plates contain-
ing kanamycin (20 mg/ml). pLS88 was used as the negative control vector for
these experiments.
Nucleotide sequence accession number. Relevant DNA sequence of the Ton
system gene locus has been submitted to GenBank (accession no. AF001034).
RESULTS
Cloning of the H. ducreyi exbB, exbD, and tonB loci. We
found that cloned hgbA was able to confer upon E. coli EB53
(hemA aroB) (Table 1) the ability to bind human hemoglobin
(23), but this strain was unable to utilize hemoglobin as a
source of heme (data not shown). We reasoned that HgbA
expressed in E. coli EB53 might not be energized by the E. coli
Ton system, since E. coli and H. ducreyi are only distantly
related (2). An experiment was designed to clone the Ton
system of H. ducreyi which was similar to that used to clone the
Ton system of meningococci (57). A partial Sau3AI library was
transformed into E. coli IR754 (tonB hemA aroB) expressing
hgbA from the compatible plasmid pUNCH 556 (Table 1) and
plated on hemoglobin as the sole source of heme. If the he-
moglobin receptor plus gene products from certain plasmids
allowed the uptake of heme from hemoglobin, then the E. coli
heme synthesis mutation would be bypassed and growth on
hemoglobin plates would occur. Of approximately 5 3 106 total
transformants, 30 complementing clones were obtained on LB
hemoglobin plates. To confirm that these clones required
HgbA for growth on hemoglobin, plasmid DNA isolated from
each was transformed into E. coli IR754 lacking pUNCH 556
(hgbA) and again plated onto hemoglobin agar plates. Thirteen
of the 30 clones failed to grow without pUNCH 556, suggesting
that the gene products expressed from those clones were in-
sufficient to allow IR754 to utilize the heme from hemoglobin.
This screen eliminated clones which allowed the heme from
hemoglobin to leak in nonspecifically or directly comple-
mented the hemA defect in IR754. Eleven of the 13 plasmids
hybridized to the insert from pGJ300 containing the H. influ-
enzae tonB operon (33, 34) (data not shown). The two plasmids
which did not hybridize apparently suffered deletions during
propagation since they were reduced to the size of the vector.
Nine of 11 hybridizing plasmids contained a 6.5-kb hybridizing
FIG. 1. Restriction maps and phenotypes of relevant H. ducreyi exbB, exbD, and tonB clones. Not shown in pUNCH 568 are unique XbaI and XhoI vector sites used
to release the insert prior to allelic exchange. E. coli IR754 (hemA tonB aroB) containing pUNCH 556 and the indicated plasmid was inoculated onto LB medium
containing various sources of heme or dALA: hemoglobin (Hg), 100 mg/ml (6 mM hemin); heme, 50 mg/ml (77 mM) or 10 mg/ml (15 mM); heme-HSA (H-Alb), 3,300
mg/ml (50 mM), saturated at a 50% molar concentration with hemin, 16 mg/ml (25 mM); dALA, 25 mg/ml (4 mM). 1, macroscopic growth at 48 h; 2, no macroscopic
growth at 48 h.
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band; each conferred upon IR754 carrying pUNCH 556 (hgbA)
the ability to grow on LB hemoglobin agar (data not shown).
One plasmid, pUNCH 562, was chosen for further study (Fig.
1).
DNA and deduced amino acid sequence of the H. ducreyi
Ton system gene cluster. The location of the TonB gene cluster
was revealed by subcloning and deletion analysis as shown in
Fig. 1. The relevant regions were sequenced, and the order of
the genes was exbB exbD tonB. Sequences similar to 235 and
210 consensus sequences were found 114 and 82 nucleotides
(nt) upstream of the exbB start codon and were separated by 16
nt. Putative ribosome-binding sites were found at 9, 11, and 11
nt upstream of the respective exbB, exbD, and tonB ATG start
codons. Just downstream of the tonB open reading frame there
was an AT-rich region with dyad symmetry consistent with a
transcription terminator. Notably absent were sequences cor-
responding to promoters upstream of the exbD and tonB struc-
tural genes.
Comparisons of the H. ducreyi deduced amino acid se-
quences with the ExbB, ExbD, and TonB protein sequences
are shown in Fig. 2. Since the enterobacterial sequences were
closely related, E. coli was chosen as the type strain to repre-
sent them for the sake of brevity.
The percent amino acid identities and similarities are shown
in Table 2. The amino acid sequences for ExbB and ExbD were
most similar to the proteins from other members of the pas-
teurellae, and this family comprised a group separate from the
others. The ExbB and ExbD proteins were the most similar
FIG. 2. Comparison of H. ducreyi ExbB (A), ExbD (B), and TonB (C) proteins with selected Ton system homologs from other gram-negative bacteria, generated
with the programs PILEUP and PRETTYBOX. Black boxes, identical residues; grey boxes, related conserved substitutions; white boxes, nonconservative substitutions.
In panel A, the N-terminal 74 aa are not shown for Pseudomonas putida ExbB. Hd, H. ducreyi; Ph, P. haemolytica; Hi, H. influenzae; Nm, Neisseria meningitidis; Pp,
Pseudomonas putida; Ec, E. coli.
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among all the genera, whereas the sequences of the TonB
proteins were more divergent. The TonB protein of H. ducreyi
was most closely related to the TonB protein from Pasteurella
haemolytica (26).
Phenotypic characterization of the H. ducreyi Ton system.
Subcloning and deletion analyses were used to define regions
of the original plasmid pUNCH 562 required to express a
hemoglobin-utilizing phenotype. E. coli IR754(pUNCH 556)
containing subclone pUNCH 563 also demonstrated a hemo-
globin-utilizing phenotype (Fig. 1 and 3A), but not in the
absence of pUNCH 556 (hgbA) (Fig. 1). pUNCH 563 was
mutagenized by deleting the DNA between the unique BbsI
and MluI sites and replacing it with a Cmr (23) cassette to form
pUNCH 568 (Fig. 1). This deletion included all of exbD and
portions of exbB and tonB. IR754(pUNCH 556) containing the
mutagenized Ton system plasmid pUNCH 568 was unable to
grow on hemoglobin (Fig. 1 and 3B).
The reconstructed H. ducreyi hemoglobin-utilizing system in
E. coli IR754 was tested for its ability to utilize other heme
sources. E. coli IR754(pUNCH 556) grew on hemoglobin with
pUNCH 563 but not with pUNCH 568; however, both strains
grew on heme but only at relatively high concentrations (50
mg/ml). Since the presence of an intact Ton system in IR754
(pUNCH 556) was not required for growth on heme, its growth
was TonB independent (Fig. 1). Previously, we reported that
E. coli clones expressing hgbA (pUNCH 556) are somewhat
leaky in that the outer membrane is perturbed (the periplasmic
enzyme RNase leaks to the extracellular environment) (23,
69). We assume that this leakiness accounts for the strain’s
ability to grow on high levels of hemin. Neither IR754(pUNCH
556) containing pUNCH 563 nor IR754(pUNCH 556) contain-
ing pUNCH 568 grew on 50 mM HSA (3.3 mg/ml) saturated at
50% hemin (Fig. 1). Fifty micromolar HSA is about 10% of the
normal serum concentration. All strains grew on medium con-
taining dALA, confirming viability. Thus, these data indicated
that under these conditions, energized HgbA functioned as a
FIG. 3. Growth of recombinant Ton system clones on LB hemoglobin agar or
dALA (LB-ALA) E. coli IR754 (hemA tonB aroB)(pUNCH 556 [hgbA]) con-
taining either pUNCH 563 (ExbB1 ExbD1 TonB1) (A) or pUNCH 568 (ExbB2
ExbD2 TonB2) (B) was streaked onto LB agar containing hemoglobin (100
mg/ml [5 mM hemin]) or dALA (25 mg/ml [4 mM]) with antibiotic selection and
incubated at 37°C for 48 h.
FIG. 2—Continued.
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receptor for hemoglobin but not for free heme or for heme
complexed to albumin.
An H. ducreyi Ton system mutant was constructed to exam-
ine which sources of heme are utilized by TonB-dependent
receptors. Parent H. ducreyi strain 35000 was electroporated
with deletion/mutant plasmid pUNCH 568 and plated on
chloramphenicol-containing chocolate agar. To screen for pu-
tative mutants, 10 Cmr transformants were tested for the ability
to grow on hemoglobin agar, and none was able to. Shown in
Fig. 4 is the phenotype of one transformant, FX514 (DexbB
exbD tonB); it was used for further experiments. Positive con-
trol parent strain 35000 grew on hemoglobin, and negative
control strain FX504 (hgbA) did not.
Evidence that the inability of FX514 to utilize hemoglobin
was due to a specific mutation in the Ton system was obtained
as follows. The mutation in the FX514 chromosome was re-
paired by electroporating Ton system plasmid pUNCH 563
followed by selection on hemoglobin agar (Tables 1 and 3).
Since plasmid pUNCH 563 cannot replicate in H. ducreyi,
growth on hemoglobin selected for repair of the mutant Ton
system chromosomal locus. In addition, the defect in FX514
was complemented in trans by using pUNCH 1210 (Table 3).
pUNCH 1210 contains the entire Ton system insert from
pUNCH 563 in shuttle vector pLS88, which is able to replicate
in H. ducreyi (Table 1). Since both chromosomal repair and
complementation in trans restored the ability of the H. ducreyi
FX514 to grow on hemoglobin, but vector control plasmid
pLS88 did not, we concluded that the inability of FX514 to
grow on hemoglobin was due to a specific mutation in the Ton
locus (data not shown). Furthermore, the phenotype of FX514
was not due to a polar effect on downstream genes since plas-
mid pUNCH 1210 fully restored hemoglobin utilization.
Southern blotting of chromosomal DNA from FX514 con-
firmed that FX514 contained the appropriately larger HincII-
to-KpnI fragment (3.25 kb) compared to parent 35000 (3.0 kb)
(Fig. 1 and Southern blot data not shown). The HincII-to-KpnI
fragment in FX514, but not 35000, was recognized by the CAT
probe. The appropriately sized HincII-to-KpnI bands were also
FIG. 4. Growth of H. ducreyi Ton system isogenic mutant on hemoglobin
agar. H. ducreyi parent strain 35000 (wild type [wt]), FX504 (hgbA), and FX514
(DexbB exbD tonB) were streaked onto GCB-I medium containing human he-
moglobin (200 mg/ml [12 mM hemin]) or chocolate agar and incubated at 35°C
for 48 h with 5% CO2.
FIG. 5. SDS-PAGE and Western blotting of outer membranes from H. du-
creyi. The indicated strains were grown under heme-replete (1) or heme-limiting
(2) conditions, and their outer membranes were isolated and subjected to
SDS-PAGE (7.5% gel) and Coomassie staining (A) or Western blotting using
anti-HgbA sera (B). Strains were H. ducreyi parent strain 35000 (wild type),
FX504 (hgbA), and FX514 (DexbB exbD tonB). Positions of molecular mass
markers are shown at the left. HgbA, hemoglobin receptor protein; protein
bands 1, 2, and 3, previously undescribed heme-regulated proteins expressed by
Ton mutant FX514 (protein 2 refers to the lower band of the doublet). The
Western blot (B) was purposely overloaded in order to detect potential proteo-
lytic breakdown products of HgbA as a source of proteins 2 and 3 and other,
smaller proteins.




Strain Hd Ph Hi Nm Pp Ec
ExbB Hd 100 68 61 28 24 23
Ph 100 61 27 24 24
Hi 100 27 28 26
Nm 100 32 31
Pp 100 60
Ec 100
ExbD Hd 100 84 70 22 26 25
Ph 100 59 19 21 21
Hi 100 19 23 21
Nm 100 33 35
Pp 100 66
Ec 100
TonB Hd 100 41 24 19 17 23
Ph 100 13 14 9 13
Hi 100 18 21 26
Nm 100 13 17
Pp 100 25
Ec 100
a Hd, H. ducreyi; Ph, P. haemolytica; Hi, H. influenzae; Nm, Neisseria menin-
gitidis; Pp, Pseudomonas putida; Ec, E. coli.
b Calculated by pairwise comparison of the sequences aligned in Fig. 2, using
OLDDISTANCES (25, 50). The percentage is the number of identical residues
divided by the length of the shorter sequence without gaps.
TABLE 3. Growth of H. ducreyi on agar plates
containing various heme sources
Strain









35000 (wild type) 1 2 1 2 1 1
FX504 (hgbA) 2 2 1 2 1 1
FX514 (exbB exbD tonB) 2 2 1 2 1 1
FX514(pUNCH 1210) 1 2 1 2 1 1
FX514 repairc 1 2 1 2 1 1
a 1, macroscopic growth present by 48 h; 2, no macroscopic growth at 48 h.
b Concentration (micrograms per milliliter).
c The Ton system mutation in FX514 was repaired to wild type as described in
text.
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observed in pUNCH 563 and pUNCH 568, respectively, using
these probes (data not shown). These results indicated FX514
contained an allelic replacement of the Ton system. Chromo-
somal repair of FX514 resulted in a Southern blot pattern
identical to that of 35000.
Phenotype of the H. ducreyi Ton mutant on sources of heme
other than hemoglobin. In other bacteria, Ton system muta-
tions are impaired in the ability to use a variety of heme/iron
compounds transported by TonB-dependent receptors; there-
fore, the growth phenotype of FX514 was examined on other
heme-containing media that support the growth of H. ducreyi.
H. ducreyi was first heme starved (56) and then serially diluted
for use as the inoculum. There was no difference for either
mutant on hemin or catalase relative to the parent (Table 3).
All three strains grew with hemin at 50 mg/ml or catalase at 250
mg/ml but not lower amounts. None of the three strains grew
on GCB-I agar containing 33 mM HSA (2 mg/ml) saturated
with 50% hemin. Taken together, these data indicated that
utilization of hemoglobin was TonB dependent whereas utili-
zation of free hemin and catalase appeared to be TonB inde-
pendent.
Novel proteins expressed by H. ducreyi Ton system mutant
FX514. Previous work in E. coli demonstrated that Ton system
mutants are relatively iron starved based on the observation
that genes normally regulated by Fur are derepressed (48).
SDS-PAGE analysis of outer membrane proteins from H. du-
creyi Ton mutant FX514 demonstrated several heme-regulated
gene products present in increased amounts (Fig. 5A). The
major protein present in increased amounts in FX514 was
HgbA, confirming that the inability to utilize hemoglobin in
this mutant was not due to the lack of synthesis of HgbA.
Three other outer membrane proteins, designated 1, 2 (protein
2 refers to the lower band of the doublet), and 3 in Fig. 5A,
were also present in increased amounts in certain of the mu-
tants under heme-regulated conditions. Protein 1 was present
only in FX514 grown under heme-limiting conditions. Proteins
2 and 3, although present in strain 35000, were more highly
expressed in the two mutants than in strain 35000 under heme
limitation. In experiments not presented here, Western blot-
ting of H. ducreyi using specific antibodies to proteins 2 and 3
demonstrate they were clearly heme regulated, albeit at lower
amounts than HgbA (data not shown). Outer membranes pre-
pared from FX514 which had been repaired by chromosomal
transformation regained the protein expression pattern of par-
ent strain 35000 (data not shown).
In some gels, including Fig. 5A, two minor proteins of ap-
proximately 60 and 65 kDa were present in slightly increased
amounts in 35000 and FX514 grown under heme limitation. It
was possible that these lower-molecular-weight protein bands
present only in 35000 and FX514 were breakdown products of
HgbA, since they were absent in FX514. Immunologically re-
active material in Western blots of H. ducreyi in this size range
have been occasionally observed in assays using antisera to
HgbA (data not shown). To address this issue, a Western blot
of these preparations was probed with polyclonal antiserum to
purified HgbA (Fig. 5B). The gel used for this blot was inten-
tionally overloaded to visualize minor breakdown products of
HgbA. Besides the expected reactivity to HgbA, reactivity to
protein 1, but not protein 2, protein 3, or smaller bands present
in strain 35000 or FX514, by this antiserum was observed.
These data are consistent with derepression of the several
genes encoding heme/iron-regulated outer membrane pro-
teins.
DISCUSSION
Utilization of hemoglobin is TonB dependent. Several TonB-
dependent receptors for heme or hemoglobin have been
cloned from gram-negative pathogens, utilizing a strategy
based on the complementation of a heme synthesis defect
(hemA) or iron acquisition (aroB) defect in E. coli (20, 29–31,
42, 57–59, 62). This method relies on the principle that E. coli
K-12 strains are unable to transport hemin or hemoglobin
across the outer membrane. However, once hemin traverses
the outer membrane, E. coli K-12 strains are able transport it
across the cytoplasmic membrane, where it can be used to
fulfill its heme or iron requirements. Using this method, we
have also attempted to clone a heme receptor from H. ducreyi
in E. coli EB53 (hemA aroB), but initial experiments have been
unsuccessful. This failure, coupled with our inability to dem-
onstrate a TonB-dependent hemoglobin utilizing phenotype in
E. coli EB53 with cloned hgbA, prompted us to search for an
explanation. It was found that the cloned H. ducreyi hgbA
receptor required its homologous Ton system in E. coli for
growth on hemoglobin. Furthermore, the Ton system mutant
FX514 was unable to utilize hemoglobin at wild-type levels,
unambiguously demonstrating that HgbA was TonB depen-
dent.
Since the deletion plasmid used to construct the H. ducreyi
Ton system mutant contained deletions in exbB, exbD, and
tonB genes, it is not possible to infer if the Ton system could
function in the absence of only a single protein. However, it
should be noted that in E. coli, most null mutations in any three
of these genes result in the total or partial loss of function for
the Ton system.
Role of HgbA in heme utilization. In an experiment to ex-
amine the role of HgbA in heme acquisition, we tested whether
cloned HgbA with its homologous Ton system could confer
upon E. coli hemA tonB aroB strains the ability to grow on free
hemin or hemin complexed to HSA. No growth was observed
on HSA-heme agar. Growth on hemin agar was observed only
at high concentrations (50 mg/ml) and growth was TonB inde-
pendent, suggesting that HgbA alone does not function as a
typical TonB-dependent receptor for free hemin or hemin
complexed to HSA. This finding does not rule out the possi-
bility that HgbA is involved in internalization of free hemin in
H. ducreyi but may indicate that additional components are
required. Alternatively, HgbA and other (heme/iron) receptors
may form a complex, and the absence of HgbA may disturb the
function of this complex. Similar nonspecific defects in the
uptake of iron compounds have been found for TonB-depen-
dent receptor mutants in other bacteria (1, 6).
Utilization of heme or catalase in H. ducreyi is TonB inde-
pendent. Although neither H. ducreyi FX504 nor FX514 grew
on hemoglobin as a sole source of heme, both mutants exhib-
ited no such growth defect on hemin relative to parent 35000
when prestarved for heme by growth anaerobically in the ab-
sence of heme. Further, all three strains required relatively
high concentrations of free hemin (50 mg/ml) for growth on
plates. To date, bacteria containing documented heme recep-
tors require much less heme (less than 10 mg/ml) than H. du-
creyi to fulfill their iron requirement. The requirement of the
wild-type H. ducreyi strain for high concentrations of heme is
reminiscent of certain mutants of H. influenzae. H. influenzae
tonB (34) or hxuC (17) mutants require high levels of heme (50
mg/ml), whereas wild-type strains require only 10 mg/ml or less
(0.1 mg/ml) (60). Most previous studies have either shown the
TonB dependence or implied the TonB dependence of heme
uptake (20, 29–31, 42, 57–59, 62). However, in contrast to these
previous studies, in Neisseria spp., heme utilization has very
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recently been shown to be TonB independent (7, 57). No heme
receptor has been found in Neisseria spp.
The growth of H. ducreyi on catalase was also TonB indepen-
dent. We confirmed the ability of H. ducreyi to grow on catalase
by using highly purified preparations (Sigma C-100), which
demonstrated a single band by SDS-PAGE. It remains unclear
whether a specific receptor for catalase exists or whether cata-
lase releases hemin upon prolonged incubation; however, a
comparison of the appearance (color) of catalase plates with
that of hemin plates indicates that there is insufficient free
heme present in the former to support the growth of H. ducreyi.
Previous studies have reported that the addition of FCS
improves the growth of H. ducreyi (3). The addition of FCS to
plates containing dilutions of heme or catalase reduced the
requirements of strain 35000 to 1 mg/ml for both heme and
catalase (data not shown). However, FCS did not lower the
requirements for heme or catalase for mutants FX504 and
FX514. These results are difficult to interpret and suggest
several possibilities. The simplest explanation is that FCS con-
tains contaminating hemoglobin. Another possibility is that
FCS contains a heme/iron source whose utilization requires
the expression of both HgbA and the Ton system. It is also
possible that FCS enhances the uptake of heme or catalase or
expression of heme or catalase receptors. Experiments are
currently under way to address these issues.
Our inability to obtain growth of H. ducreyi on heme-albu-
min is in contrast to previous studies (3, 39). These differences
could at least be partially explained by differences in materials
and methods (percent heme saturation and inoculation differ-
ences) used in the various studies.
The H. ducreyi Ton system mutant expresses novel heme-
regulated outer membrane proteins. Regulation of most iron-
repressed genes in E. coli is under the control of the global
negative repressor Fur (4). In E. coli, derepression of the Fur
regulon in tonB mutants is believed to be due the inability to
transport iron by means of the various TonB-dependent recep-
tors, resulting in low intracellular iron levels (47). H. ducreyi
contains a functional Fur protein (14); however, the H. ducreyi
genes regulated by Fur have not yet been identified. In H.
ducreyi, expression of hgbA and perhaps hemolytic activity (9,
23) are regulated by the levels of heme in the medium. Since
heme and hemoglobin contain iron, it is possible that these
heme sources also serve as a source of intracellular iron, there-
by indirectly affecting expression of the H. ducreyi Fur regulon.
H. ducreyi Ton system mutant FX514 demonstrated increased
expression of HgbA as well as several previously undescribed
outer membrane proteins, which appeared to be regulated by
the levels of heme in the medium. The possibility that these
novel proteins are involved in heme/iron acquisition is consis-
tent with observations made in other pathogens. Further work
is needed in this area to understand the repertoire of receptors
for heme/iron compounds in H. ducreyi and their regulation.
Structure and arrangement of the H. ducreyi Ton system.
The arrangement of genes in the H. ducreyi tonB cluster was
similar to that in certain other gram-negative bacteria de-
scribed elsewhere (8, 33, 34), with the order exbB exbD tonB.
The arrangement, the DNA sequence, and the proximity of the
structural genes suggested that only one promoter was respon-
sible for expression of all three genes. We speculate that these
genes may be transcribed as a multicistronic message; however,
this remains to be proven experimentally.
Significant diversity exists between the H. ducreyi and E. coli
TonB proteins. These differences could account for the inabil-
ity of the H. ducreyi HgbA receptor to function together with
the E. coli EB53 Ton system. However, three of four general
domains previously described for E. coli TonB were present in
H. ducreyi TonB (38, 65). The sequence of the N-terminal
hydrophobic region (amino acids [aa] 12 to 32) (36) spans the
cytoplasmic membrane in E. coli and may interact with ExbB.
H. ducreyi TonB contains three of four invariant residues in
this N-terminal region compared to E. coli. The second domain
traverses the periplasmic space in E. coli and contains the
characteristic X-Pro repeat region (aa 63 to 102) and is present
in the H. ducreyi sequence. A third short sequence has been
implicated in the interaction of TonB with outer membrane
receptors and consists of YPARA (aa 160 to 167) in E. coli and
YPARE in H. ducreyi. The fourth domain of TonB (aa 199 to
216) in E. coli, predicted to form an alpha helix, is present in
all enteric species yet is so diverged in both Haemophilus spe-
cies that no primary sequence homology exists. Four monoclo-
nal antibodies against E. coli TonB (38) failed to react with
H. ducreyi TonB (data not shown), providing further evidence
of the dissimilarity between the TonB proteins of E. coli and
H. ducreyi. Despite these dissimilarities, the E. coli proton
motive force can be transduced through the H. ducreyi TonB to
HgbA, suggesting that certain critical interacting domains are
present. The reconstituted system in E. coli containing HgbA
and the H. ducreyi Ton system also contains ExbB and ExbD
proteins from E. coli. It is not clear whether it is the E. coli or
H. ducreyi versions of ExbB and ExbD proteins that interact
with H. ducreyi TonB.
It has recently been shown that an hgbA (hupA) mutant of
strain 35000 (56) is less virulent in a temperature-dependent
rabbit model of infection. In this model, lesion scores were
smaller and isolation of the mutant from lesions was unsuc-
cessful. We have confirmed this finding by using FX504 (23a)
and have similar data from a swine ear model of infection (23b,
32). These results suggest that the acquisition of hemoglobin is
vital for this pathogen to survive and produce disease in vivo.
We predict that a Ton mutant would have similar or possibly
even more profound virulence defects based on its inability to
utilize hemoglobin and possibly other heme compounds trans-
ported by TonB-dependent receptors.
Our results implicate several novel outer membrane proteins
which were more highly expressed in the Ton system mutant
and might be additional TonB-dependent receptors to study.
Mutagenesis of the genes encoding these putative novel recep-
tors might give insights into their function for the acquisition of
heme- or iron-containing compounds utilized by H. ducreyi.
Lastly, assuming that additional H. ducreyi TonB-dependent
receptors exist for sources of heme other than hemoglobin, we
hope to clone appropriate homologous receptors by functional
complementation of E. coli IR754(pUNCH 563) and selecting
on appropriate heme sources.
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